Skip to main content

Advertisement

SpringerLink
Log in

Esomeprazole-induced rhabdomyolysis in a patient with heart failure

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Huerta-Alardin AL, Varon J, Marik PE (2005) Bench-to-bedside review: rhabdomyolysis—an overview for clinicians. Crit Care 9:158–169

    Article  PubMed  Google Scholar 

  2. Mikkelsen TS, Toft P (2005) Prognostic value, kinetics and effect of CVVHDF on serum of the myoglobin and creatine kinase in critically ill patients with rhabdomyolysis. Acta Anaesthesiol Scand 49:859–864

    Article  PubMed  CAS  Google Scholar 

  3. Quenot JP, Thiery N, Barbar S (2009) When should stress ulcer prophylaxis be used in the ICU? Curr Opin Crit Care 15:139–143

    Article  PubMed  Google Scholar 

  4. Clark DWJ, Strandell J (2006) Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors? Eur J Clin Pharmacol 62:473–479

    Article  PubMed  CAS  Google Scholar 

  5. Wilder-Smith CH, Bondarov P, Lundgren M, Niazi M, Röhss K, Ahlbom H, Nyman L (2005) Intravenous esomeprazole (40 mg and 20 mg) inhibits gastric acid secretion as effectively as oral esomeprazole: results of two randomized clinical studies. Eur J Gastroenterol Hepatol 17:191–197

    Article  PubMed  CAS  Google Scholar 

  6. Sivakumar K, Dalakas MC (1994) Autoimmune syndrome induced by omeprazole. Lancet 344:619–620

    Article  PubMed  CAS  Google Scholar 

  7. Schönhöfer PS, Werner B, Tröger U (1997) Ocular damage associated with proton pump inhibitors. Br Med J 314:1805

    Google Scholar 

Download references

Conflict of interest statement

We certify that there is no actual or potential conflict of interest in relation to this article.

Author information

Authors and Affiliations

  1. Institute of Clinical Pharmacology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany

    Uwe Tröger, Ines Reiche & Stefanie M. Bode-Böger

  2. Clinic for Heart and Thoracic Surgery, Otto-von-Guericke-University Magdeburg, Leipziger Str. 44, Magdeburg, Germany

    Marilene S. Jepsen & Christof Huth

Authors
  1. Uwe Tröger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ines Reiche
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marilene S. Jepsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christof Huth
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stefanie M. Bode-Böger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Uwe Tröger.

Additional information

U. Tröger and I. Reiche contributed equally to the paper.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tröger, U., Reiche, I., Jepsen, M.S. et al. Esomeprazole-induced rhabdomyolysis in a patient with heart failure. Intensive Care Med 36, 1278–1279 (2010). https://doi.org/10.1007/s00134-010-1854-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-010-1854-0

Keywords

Search

Navigation